Article
Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories.
Journal of clinical pathology - 1 Mar 2008
Wordsworth S, Papanicolas I, Buchanan J, Frayling I, Taylor J, Tomlinson I
Abstract excerpt
BACKGROUND: Genetics clinical practice has paid limited attention to non-inherited aspects of cancer, namely mutations occurring during carcinogenesis. These somatic mutations are likely to be the primary determinants of cancer behaviour and treatment response, with a recent example being Her2/Neu gene status and response to Herceptin in breast cancer. AIM: To assess the feasibility of widespread testing of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
